The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice

• Published in: Molecular cancer research 2019-07, Vol.17 (7), p.1468-1479
• Main Authors: Tracey, Lauren J, Brooke-Bisschop, Travis, Jansen, Pascal W T C, Campos, Eric I, Vermeulen, Michiel, Justice, Monica J
• Format: Article
• Language: English
• Subjects: Animals; Disease Models, Animal; DNA Methylation - genetics; DNA-Binding Proteins - genetics; Hematopoietic Stem Cells - metabolism; Hematopoietic Stem Cells - pathology; Humans; Mice; Neoplastic Stem Cells - metabolism; Neoplastic Stem Cells - pathology; Pluripotent Stem Cells - metabolism; Pluripotent Stem Cells - pathology; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology; Repressor Proteins - genetics; RNA-Binding Proteins - genetics; Transcription Factors - genetics
• ISSN: 1541-7786; 1557-3125
• DOI: 10.1158/1541-7786.mcr-18-1327

PR domain-containing 14 ( ) is a pluripotency regulator central to embryonic stem cell identity and primordial germ cell specification. Genomic regions containing are often amplified leading to misexpression in human cancer. expression in mouse hematopoietic stem cells (HSC) leads to progenitor cell expansion prior to the development of T-cell acute lymphoblastic leukemia (T-ALL), consistent with PRDM14's role in cancer initiation. Here, we demonstrate mechanistic insight into PRDM14-driven leukemias . Mass spectrometry revealed novel PRDM14-protein interactions including histone H1, RNA-binding proteins, and the master hematopoietic regulator CBFA2T3. In mouse leukemic cells, CBFA2T3 and PRDM14 associate independently of the related ETO family member CBFA2T2, PRDM14's primary protein partner in pluripotent cells. CBFA2T3 plays crucial roles in HSC self-renewal and lineage commitment, and participates in oncogenic translocations in acute myeloid leukemia. These results suggest a model whereby PRDM14 recruits CBFA2T3 to DNA, leading to gene misregulation causing progenitor cell expansion and lineage perturbations preceding T-ALL development. Strikingly, -induced T-ALL does not occur in mice deficient for , demonstrating that is required for leukemogenesis. Moreover, T-ALL develops in heterozygotes with a significantly longer latency, suggesting that PRDM14-associated T-ALL is sensitive to levels. Our study highlights how an oncogenic protein uses a native protein in progenitor cells to initiate leukemia, providing insight into PRDM14-driven oncogenesis in other cell types. IMPLICATIONS: The pluripotency regulator PRDM14 requires the master hematopoietic regulator CBFA2T3 to initiate leukemia in progenitor cells, demonstrating an oncogenic role for CBFA2T3 and providing an avenue for targeting cancer-initiating cells.